Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.50
-0.34 (-4.97%)
At close: Mar 6, 2026, 4:00 PM EST
6.55
+0.05 (0.77%)
After-hours: Mar 6, 2026, 7:55 PM EST
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 485 employees as of December 31, 2025. The number of employees decreased by 349 or -41.85% compared to the previous year.
Employees
485
Change (1Y)
-349
Growth (1Y)
-41.85%
Revenue / Employee
$204,023
Profits / Employee
-$375,016
Market Cap
378.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 305 |
| Absci | 157 |
| Enanta Pharmaceuticals | 120 |
| Aclaris Therapeutics | 73 |
| Armata Pharmaceuticals | 60 |
| PepGen | 57 |
| Shattuck Labs | 44 |
| Candel Therapeutics | 38 |
DNA News
- 6 days ago - Ginkgo Bioworks Makes Major Pivot - Seeking Alpha
- 6 days ago - Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - PRNewsWire
- 9 days ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter - Benzinga
- 10 days ago - Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business - PRNewsWire
- 17 days ago - Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - PRNewsWire
- 18 days ago - Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products - PRNewsWire
- 4 weeks ago - Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark - PRNewsWire